Hydrogenology
Source-linked study record

Hemodialysis employing molecular hydrogen (H₂) enriched dialysis solution may improve dialysis related fatigue through impact on energy metabolism

Nakayama M, Watanabe K, Sato E, et al. · Scientific Reports. 2025;15:5039.

HumanOther formsPublished 2025Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Human

Population or model

Adults receiving maintenance hemodialysis at one outpatient center.

Intervention and dose

All clinic patients switched from standard hemodialysis to an electrolyzed-water hemodialysis system containing dissolved H₂. · Final dialysate contained 70–130 ppb dissolved H₂; composition, electrolytes and pH otherwise matched standard dialysate.

Duration

Three sessions/week, 4–5 hours/session, followed for 12 months.

Reported result

In the 25-person fatigue-with-activity-reduction group, dialysis-day fatigue fell from 5.56±1.33 to 3.56±2.47 at 12 months (within-group p<0.05); no change occurred in the other baseline groups. HD-free-day fatigue was not significantly changed overall. NETosis markers were null; metabolomic findings were exploratory and based on 35 selected samples.

Main limitation

No concurrent control, universal clinic-wide switch, subjective fatigue, older single-center cohort and regression to the mean are major limitations. The metabolomic pathway interpretation is exploratory. Eleven consented patients did not complete follow-up. Tohoku University Hospital funding was reported; authors declared no competing interests.

Evidence and classification

What kind of evidence is this?

Evidence type

Human

Reported design

Prospective single-center uncontrolled before-and-after observational study

Research topic

Kidney and urinary health

Administration form

Other forms

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Adults receiving maintenance hemodialysis at one outpatient center.

Sample

92 consented; 81 completed 12 months and were analyzed: 25 with fatigue reducing activity, 24 with fatigue without activity reduction and 32 without fatigue.

Duration

Three sessions/week, 4–5 hours/session, followed for 12 months.

Intervention

All clinic patients switched from standard hemodialysis to an electrolyzed-water hemodialysis system containing dissolved H₂.

Hydrogen form

H₂ dissolved in dialysis solution — not inhaled, not swallowed and not Brown's gas.

Dose or H₂ specification

Final dialysate contained 70–130 ppb dissolved H₂; composition, electrolytes and pH otherwise matched standard dialysate.

Comparator

Participants' standard-hemodialysis baseline; no concurrent control group.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Fatigue numerical rating scales, body composition, biocompatibility markers, uremic toxins and exploratory metabolomics.

Reported result

In the 25-person fatigue-with-activity-reduction group, dialysis-day fatigue fell from 5.56±1.33 to 3.56±2.47 at 12 months (within-group p<0.05); no change occurred in the other baseline groups. HD-free-day fatigue was not significantly changed overall. NETosis markers were null; metabolomic findings were exploratory and based on 35 selected samples.

Extraction completeness

The complete Scientific Reports article, participant flow, dialysate concentration, all fatigue time points, body-composition, null biocompatibility results, metabolomics, funding and competing interests were checked.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

No concurrent control, universal clinic-wide switch, subjective fatigue, older single-center cohort and regression to the mean are major limitations. The metabolomic pathway interpretation is exploratory. Eleven consented patients did not complete follow-up. Tohoku University Hospital funding was reported; authors declared no competing interests.

Applies directly to

Maintenance-hemodialysis patients in this outpatient program; not evidence for drinking or inhaling H₂.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 39934143 · DOI: 10.1038/s41598-025-88827-2

Publisher access

Open-access full article on Scientific Reports and PMC.

Extraction basis

Scientific Reports publisher and PMC full articles plus PubMed record; full-text and article-status check completed 8 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.